Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

Similar articles for PubMed (Select 23493042)

1.

Blockade of Tau hyperphosphorylation and Aβ₁₋₄₂ generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and σ₁ receptor agonist, in a nontransgenic mouse model of Alzheimer's disease.

Lahmy V, Meunier J, Malmström S, Naert G, Givalois L, Kim SH, Villard V, Vamvakides A, Maurice T.

Neuropsychopharmacology. 2013 Aug;38(9):1706-23. doi: 10.1038/npp.2013.70. Epub 2013 Mar 14.

2.

Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma 1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative.

Villard V, Espallergues J, Keller E, Vamvakides A, Maurice T.

J Psychopharmacol. 2011 Aug;25(8):1101-17. doi: 10.1177/0269881110379286. Epub 2010 Sep 9.

PMID:
20829307
3.

FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.

Bao XQ, Li N, Wang T, Kong XC, Tai WJ, Sun H, Zhang D.

PLoS One. 2013 Nov 4;8(11):e78033. doi: 10.1371/journal.pone.0078033. eCollection 2013.

4.

Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.

Zhang Z, Zhao R, Qi J, Wen S, Tang Y, Wang D.

J Neurosci Res. 2011 Mar;89(3):437-47. doi: 10.1002/jnr.22563. Epub 2010 Dec 17.

PMID:
21259330
5.

Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.

Xian YF, Mao QQ, Wu JC, Su ZR, Chen JN, Lai XP, Ip SP, Lin ZX.

J Alzheimers Dis. 2014;39(2):331-46. doi: 10.3233/JAD-131457.

PMID:
24164737
6.

Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3β pathway in ginsenoside Rb1's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation.

Zhao R, Zhang Z, Song Y, Wang D, Qi J, Wen S.

J Ethnopharmacol. 2011 Feb 16;133(3):1109-16. doi: 10.1016/j.jep.2010.11.054. Epub 2010 Dec 1. Retraction in: J Ethnopharmacol. 2012 Jun 14;141(3):1080.

PMID:
21129477
7.

Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cells.

Hu M, Waring JF, Gopalakrishnan M, Li J.

J Neurochem. 2008 Aug;106(3):1371-7. doi: 10.1111/j.1471-4159.2008.05483.x. Epub 2008 May 15.

PMID:
18485099
8.

Antiamnesic and neuroprotective effects of the aminotetrahydrofuran derivative ANAVEX1-41 against amyloid beta(25-35)-induced toxicity in mice.

Villard V, Espallergues J, Keller E, Alkam T, Nitta A, Yamada K, Nabeshima T, Vamvakides A, Maurice T.

Neuropsychopharmacology. 2009 May;34(6):1552-66. doi: 10.1038/npp.2008.212. Epub 2008 Dec 3.

9.

M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy.

Fisher A, Pittel Z, Haring R, Bar-Ner N, Kliger-Spatz M, Natan N, Egozi I, Sonego H, Marcovitch I, Brandeis R.

J Mol Neurosci. 2003;20(3):349-56. Review.

PMID:
14501019
10.

Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway.

Hoppe JB, Coradini K, Frozza RL, Oliveira CM, Meneghetti AB, Bernardi A, Pires ES, Beck RC, Salbego CG.

Neurobiol Learn Mem. 2013 Nov;106:134-44. doi: 10.1016/j.nlm.2013.08.001. Epub 2013 Aug 14.

PMID:
23954730
11.

The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's disease.

Lanzillotta A, Sarnico I, Benarese M, Branca C, Baiguera C, Hutter-Paier B, Windisch M, Spano P, Imbimbo BP, Pizzi M.

J Mol Neurosci. 2011 Sep;45(1):22-31. doi: 10.1007/s12031-010-9482-2. Epub 2010 Dec 22.

PMID:
21181298
12.

Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neurons.

Forlenza OV, Spink JM, Dayanandan R, Anderton BH, Olesen OF, Lovestone S.

J Neural Transm. 2000;107(10):1201-12.

PMID:
11129110
13.

17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.

Shi HR, Zhu LQ, Wang SH, Liu XA, Tian Q, Zhang Q, Wang Q, Wang JZ.

J Neural Transm. 2008 Jun;115(6):879-88. doi: 10.1007/s00702-008-0021-z. Epub 2008 Jan 24. Erratum in: J Neural Transm. 2010 May;117(5):679-80.

PMID:
18217188
14.

Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease.

Peng Y, Hu Y, Xu S, Rong X, Li J, Li P, Wang L, Yang J, Wang X.

J Pharmacol Exp Ther. 2014 Aug;350(2):361-74. doi: 10.1124/jpet.114.213140. Epub 2014 Jun 3.

PMID:
24893984
15.

TL-2 attenuates β-amyloid induced neuronal apoptosis through the AKT/GSK-3β/β-catenin pathway.

Zhu X, Wang S, Yu L, Yang H, Tan R, Yin K, Jin J, Zhao H, Guan D, Xu Y.

Int J Neuropsychopharmacol. 2014 Sep;17(9):1511-9. doi: 10.1017/S1461145714000315. Epub 2014 Mar 19.

PMID:
24641999
16.
17.

A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo.

Serenó L, Coma M, Rodríguez M, Sánchez-Ferrer P, Sánchez MB, Gich I, Agulló JM, Pérez M, Avila J, Guardia-Laguarta C, Clarimón J, Lleó A, Gómez-Isla T.

Neurobiol Dis. 2009 Sep;35(3):359-67. doi: 10.1016/j.nbd.2009.05.025. Epub 2009 Jun 10.

PMID:
19523516
18.

Age-dependent accumulation of soluble amyloid beta (Abeta) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3beta pathway in Alzheimer mouse model.

Jimenez S, Torres M, Vizuete M, Sanchez-Varo R, Sanchez-Mejias E, Trujillo-Estrada L, Carmona-Cuenca I, Caballero C, Ruano D, Gutierrez A, Vitorica J.

J Biol Chem. 2011 May 27;286(21):18414-25. doi: 10.1074/jbc.M110.209718. Epub 2011 Apr 1.

19.

Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.

Koh SH, Noh MY, Kim SH.

Brain Res. 2008 Jan 10;1188:254-62. Epub 2007 Nov 1.

PMID:
18031715
20.

Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.

Chen S, An FM, Yin L, Liu AR, Yin DK, Yao WB, Gao XD.

Neuroscience. 2014 Jan 3;256:137-46. doi: 10.1016/j.neuroscience.2013.10.038. Epub 2013 Oct 30.

PMID:
24183963
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk